[HTML][HTML] Lung volume reduction surgery versus endobronchial valves: a randomised controlled trial

SC Buttery, W Banya, R Bilancia, E Boyd… - European …, 2023 - Eur Respiratory Soc
Background Lung volume reduction surgery (LVRS) and bronchoscopic lung volume
reduction (BLVR) with endobronchial valves can improve outcomes in appropriately …

[HTML][HTML] Real-World and Patient-Reported Outcomes of Dupilumab and Other Biological Drugs for Chronic Obstructive Pulmonary Disease—A Systematic Review

O Freund, O Wand, S Kutzkel, B Tiran, I Pumin… - Diagnostics, 2024 - mdpi.com
Background: Over the last few decades, the efficacy of biological therapies for COPD has
been evaluated by different randomized controlled trials (RCTs). Still, the evaluation of real …

COPD assessment test in bronchiectasis: minimum clinically important difference and psychometric validation: a prospective study

D De la Rosa Carrillo, C Olveira, M García-Clemente… - Chest, 2020 - Elsevier
Background Health-related quality of life (QoL) is one of the most important end points in
bronchiectasis (BE). However, the majority of health-related QoL questionnaires are time …

The value of FENO measurement for predicting treatment response in patients with acute exacerbation of chronic obstructive pulmonary disease

A Zhou, Z Zhou, D Deng, Y Zhao, J Duan… - … Journal of Chronic …, 2020 - Taylor & Francis
Background Fractional exhaled nitric oxide (FENO) has been shown to be a marker of
airway inflammation in various pulmonary diseases, including chronic obstructive pulmonary …

CODEXS: a new multidimensional index to better predict frequent COPD exacerbators with inclusion of depression score

D Deng, A Zhou, P Chen, Q Shuang - International Journal of …, 2020 - Taylor & Francis
Purpose Depression is reported in association with chronic obstructive pulmonary disease
(COPD). However, to date, no multidimensional indices have taken depression into …

Nemonoxacin achieved a better symptomatic improvement and a prolonged interval to next exacerbation than moxifloxacin for outpatients with acute exacerbations of …

W Meng, H Zeng, Z Zhao, R Xiong, Y Chen, Z Li - Scientific Reports, 2023 - nature.com
Nemonoxacin is a novel non-fluorinated quinolone with strong antibacterial efficacy, but
data of its effect on acute exacerbations of chronic obstructive pulmonary disease …

[HTML][HTML] 圣乔治呼吸问卷, CAT 及mMRC 评分在慢性阻塞性肺病中的应用

孟现玲, 何玉廷, 毛若琳, 陈智鸿 - 2022 - jms.fudan.edu.cn
目的探讨3 种呼吸问卷评分之间的相关性及其与肺通气功能严重程度的相关性,
了解现有的呼吸问卷用于评估慢性阻塞性肺病(chronic obstructive pulmonary disease, COPD) …

[PDF][PDF] Efektivitas Pengobatan pada Pasien Penyakit Paru Obstruksi Kronis (PPOK) di Rumah Sakit Wilayah Yogyakarta

CP Sari, S Hanifah, R Rosdiana… - Jurnal Manajemen Dan …, 2021 - academia.edu
ABSTRAK Penyakit Paru Obstruksi Kronik (PPOK) merupakan gangguan pernafasan
kompleks yang memerlukan berbagai macam pendekatan untuk menilai respon …

Usefulness of the mini nutritional assessment short-form for evaluating nutritional status in patients with nontuberculous mycobacterial pulmonary disease: a …

E Chung, Y Park, HJ Lee, YA Kang - BMC Infectious Diseases, 2024 - Springer
Abstract Background Although the Mini Nutritional Assessment (MNA) is recognized as a
useful tool for evaluating nutritional status in patients with various diseases, its applicability …

Correlations between serum decoy receptor 3 and airflow limitation and quality of life in male patients with stable stage and acute exacerbation of COPD

H Ghobadi, N Hosseini, MR Aslani - Lung, 2020 - Springer
Abstract Purpose Serum decoy receptor 3 (DcR3) level increases in chronic inflammatory
diseases. The present study aimed to examine serum DcR3 and IL-6 levels in male patients …